Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Crispr Therapeutics Ag (NQ: CRSP )

116.48 USD -2.74 (-2.30%)
Streaming Delayed Price Updated: 1:54 PM EDT, Jul 27, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Crispr Therapeutics Ag

< Previous 1 2 3 4 5 6 7 8 9
...
28 29 Next >
The 3 Best Healthcare Stocks to Buy for 2021
All three could be huge winners in the new year -- and over the long run. 
Tags ISRG Market News VRTX
From Motley Fool
Interesting CRSP Put And Call Options For February 2021
Investors in CRISPR Therapeutics AG (CRSP) saw new options begin trading today, for the February 2021 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CRSP... 
Tags Stocks
From Market News Video
Are Genomic Stocks Are The Next FANG Stocks?
Some of the best performing ETFs in 2020 have been the Ark Funds, actively managed ETFs led by Cathie Wood. A long-time Tesla Inc ... 
Tags General FB Health Care
From Benzinga
Where to Invest $5,000 Right Now
If you're worried another market crash is imminent, you'll want to scoop up these three stocks soon. 
Tags ZM MRNA VRTX
From Motley Fool
The 3 Best Stocks for 2021
A beaten-down biotech, a streaming star, and a coronavirus testing giant could be well-rounded additions to your portfolio. 
Tags VRTX CRSP DIS
From Motley Fool
Cramer Weighs In On Salesforce, General Motors And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said Salesforce.com, inc. (NYSE: CRM) was up big on Tuesday and it still ... 
Tags HYLN mad money Lightning Round CNBC
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
Wednesday morning saw 335 companies set new 52-week highs. Noteworthy Highlights: The company with the largest market ... 
Tags ALPN INTU FEYE
From Benzinga
Return On Capital Employed Overview: CRISPR Therapeutics
During Q3, CRISPR Therapeutics's (NASDAQ: CRSP) reported sales totaled $148.00 thousand. Despite a 14.51% in earnings, the company ... 
Tags Earnings Market News Benzinga
From Benzinga
The Daily Biotech Pulse: Ziopharm To Start Blood Cancer Study, Chemocentryx & Soligenix Slump On Adverse Clinical Trial Outcomes
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags NEO PLXP ZLAB
From Benzinga
Genetics Stocks Ablaze: Editas, Crispr, Intellia Rocket; Uniqure Dives
Crispr Therapeutics, Editas Medicine and Intellia Therapeutics were ablaze Monday as all three genetics stocks hit highs. Uniqure stock tumbled on a clinical hold for its gene therapy test. 
From Investor's Business Daily
Why Editas Medicine Stock Is Skyrocketing Today
Here are some best guesses about the biotech stock's huge jump. 
Tags Market News CRSP EDIT
From Motley Fool
3 Biotech Stocks That Could Explode Higher in 2021
Here's how three nascent drugmakers could make 2021 a banner year for your portfolio. 
Tags CRSP ALXN Market News
From Motley Fool
3 Top Biotech Stocks to Buy Right Now
Each of them should enjoy strong sales growth in 2021 and beyond. 
Tags EXEL BMY VRTX
From Motley Fool
Megatrends To Invest In Now: 3 Best ETF Picks
BlackRock has identified five big trends that are here to stay for the long haul. Investors can get exposure to these drivers via 17 iShares ETFs. 
From Investor's Business Daily
Are These The Top Biotech Stocks To Watch This Week? 1 Up By 95% On Monday
From StockMarket.com
Where Will CRISPR Therapeutics Be in 10 Years?
This gene-editing leader's current programs only reveal a hint of what it could become. 
Tags Market News GOOG CRSP
From Motley Fool
Making A List Of Biotech Stocks To Watch This Week? 1 Jumped More Than 200% In Q4
From StockMarket.com
If You Have $1,000 and 5 Years to Wait, Buy These 2 Stocks Now
These disruptive biotech stocks could prove to be great investments in the long run. 
Tags CRSP Market News VRTX
From Motley Fool
Watch Out bluebird bio, CRISPR Is on Your Heels
The battle for beta thalassemia and sickle cell disease patients is heating up. 
Tags BLUE Market News CRSP
From Motley Fool
3 Stocks That Are Giving Their Investors Coal in Their Stockings
Naughty or nice, shareholders aren't getting anything on their wish lists from these stocks this year. 
Tags ABBV GILD SAGE
From Motley Fool
Five investing rules from a money manager who crushes the stock market — and his take on the best companies to own now
Alexander Ely of the Delaware Smid Cap Growth Fund invests in disruptive companies including Square, Boston Beer and Yeti. 
Tags BHC SAM SPX
From MarketWatch
Is CRISPR Therapeutics Heading for $170
Analysts have been raising their price targets on the stock based on news about a treatment the biotech is developing in partnership with Vertex Pharmaceuticals. 
Tags VRTX BLUE Market News
From Motley Fool
Why Editas Medicine Stock Is Rising for a Third Consecutive Day
Momentum continues from the biotech's weekend presentation of promising data for its experimental sickle cell disease therapy. 
Tags Market News EDIT CRSP
From Motley Fool
The Daily Biotech Pulse: ASH Presentations, Axsome's Positive Midstage Readout, Follow-On Offerings
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags LYRA FATE PACB
From Benzinga
How You Can Profit From the Best-Managed Drugmaker on Earth
One metric shows that decades of dominance treating diabetes has created unrivaled profitability. 
Tags LLY Market News EDIT
From Motley Fool
Why Editas Medicine Stock Is Soaring Today
Investors liked the biotech's update about experimental gene-editing therapy EDIT-301. 
Tags Market News CRSP EDIT
From Motley Fool
Stocks That Hit 52-Week Highs On Monday
During the morning session on Monday, 243 stocks hit new 52-week highs. Points of Interest: The largest company by ... 
Tags HBM MDRX RH
From Benzinga
Benzinga's Top Upgrades, Downgrades For December 7, 2020
Upgrades For Spirit AeroSystems Holdings Inc (NYSE: SPR), UBS upgraded the previous rating of Neutral to the current rating Buy. ... 
Tags PRTA top upgrades LW
From Benzinga
Here Are The Winners Of This Year's Biggest Blood Cancer Meeting
Biotech stocks Fate Therapeutics and Constellation Pharmaceuticals rocketed Monday on promising cancer treatment presentations offered at the American Society of Hematology meeting. 
From Investor's Business Daily
Week Ahead In Biotech: FDA To Decide On Emergency Use Of Pfizer's COVID Vaccine, Hematology Conference Presentations Pick Up Pace
Biotech stocks headed higher in the week ended Dec. 5 as broader market optimism pervaded into the sector. The sector also continued to ... 
Tags ATNX RHHBY GLYC
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
28 29 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback